Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972109priorityCriticalpatent/ECSP972109A/en
Publication of ECSP972109ApublicationCriticalpatent/ECSP972109A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Una composición para tratar una enfermedad neoplástica en mamíferos y administrar al mamífero una cantidad terapéuticamente efectiva de un interferón vía contacto oromucosal. La cantidad de interferón administrado es menor que la cantidad que induce una respuesta patológica cuando es administrada parenteralmente.A composition for treating mammalian neoplastic disease and administering to the mammal a therapeutically effective amount of an interferon via oromucosal contact. The amount of interferon administered is less than the amount that induces a pathological response when administered parenterally.
ECSP9721091997-05-081997-05-08
STIMULATION OF GUEST DEFENSE MECHANISMS AGAINST TUMORS
ECSP972109A
(en)
Process for treating vaginal dryness or sexual dysfunction in women during or after menopause and using the compound (diaminohydroxy) toremifene or a pharmaceutically acceptable salt, ester or metabolite thereof